Your browser doesn't support javascript.
loading
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice.
Sanchorawala, Vaishali; Wechalekar, Ashutosh D; Kim, Kihyun; Schönland, Stefan O; Landau, Heather J; Kwok, Fiona; Suzuki, Kenshi; Dispenzieri, Angela; Merlini, Giampaolo; Comenzo, Raymond L; Cherepanov, Dasha; Hayden, Vanessa C; Kumar, Arun; Labotka, Richard; Faller, Douglas V; Kastritis, Efstathios.
Affiliation
  • Sanchorawala V; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
  • Wechalekar AD; National Amyloidosis Centre, Royal Free London NHS Foundation Trust, University College London, London, UK.
  • Kim K; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Schönland SO; Department of Medicine V (Hematology, Oncology and Rheumatology), Amyloidosis Center Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.
  • Landau HJ; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Kwok F; Clinical Haematology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, New York, USA.
  • Merlini G; Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Comenzo RL; John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, Massachusetts, USA.
  • Cherepanov D; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
  • Hayden VC; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
  • Kumar A; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
  • Labotka R; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
  • Faller DV; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
  • Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Am J Hematol ; 98(5): 720-729, 2023 05.
Article in En | MEDLINE | ID: mdl-36708469
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Immunoglobulin Light-chain Amyloidosis / Amyloidosis / Multiple Myeloma Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Immunoglobulin Light-chain Amyloidosis / Amyloidosis / Multiple Myeloma Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: United States